Evidence map›Paper›PMID 39702247›Full record

ArticleBMC musculoskeletal disorders2024

Global, regional and national burden of osteoarthritis in 1990-2021: a systematic analysis of the global burden of disease study 2021.

Zihao Wang, Zhikang Xiao, Changhao Sun, Gaoxiang Xu, Jianfeng He

Abstract read
In one paragraph

Article in BMC musculoskeletal disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Low-power infrared laser on telomere maintenance in an experimental model of arthritis.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zihao WangThe First Clinical Medical College of Zhengzhou University, Zhengzhou, 450052, China.
Zhikang XiaoDepartment of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Changhao SunDepartment of Radiology, Guihang 300 Hospital Affiliated to Zunyi Medical University, Guiyang, 550027, China.
Gaoxiang XuDepartment of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. xugx301@163.com.
Jianfeng HeDepartment of Radiology, Guihang 300 Hospital Affiliated to Zunyi Medical University, Guiyang, 550027, China. hejf301@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo describe the prevalence and incidence of osteoarthritis as well as years lived with disability (YLDs) due to osteoarthritis in 204 countries and territories from 1990 to 2021 by age, sex and socio-demographic index (SDI, a composite of socio-demographic factors).

methodsData were acquired from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021 (GBD 2021). The burden of osteoarthritis was estimated for 204 countries and territories from 1990 to 2021by incidence, prevalence and YLDs. All estimates are presented as numbers and age-standardised rates per 100 000 population, with uncertainty intervals (UIs). All the data were analyzed by age-sex-SDI-year groups.

resultsIn 2021, globally, the age-standardised prevalence rate of osteoarthritis increased from 6393.1(95% UI 5683.2 to 7059.5) in 1990 to 6967.3(95% UI 6180.7 to 7686.1) in 2021.Addtionally, the age-standardised incidence rate increased from 489.8(95% UI 541.5 to 433.1) in 1990 to 535.0(95% UI 472.4 to 592.0) in 2021. In addition, the age-standardised YLD rate of osteoarthritis increased from 222.8(95% UI 106.7 to 450.3) in 1990 to 244.5(95% UI 117.1 to 493.1). The global prevalence and YLDs were higher in females than in males and increased with age, peaking at the > 95 years age group. Simultaneously, a positive association was found between the age-standardised YLD rate and the SDI at the regional and national levels.

conclusionsOsteoarthritis is a major public health challenge that can cause significant problems for individuals and society. The burden osteoarthritis increased in most countries between 1990 and 2021. This trend is expected to continue as life expectancy increases and the global population ages. Increasing public awareness of the risk factors and the importance of osteoarthritis management, along with providing healthcare services to the growing number of people with osteoarthritis, are recommended to manage the future burden of this disease.

Indexed as

Global Burden of DiseaseGlobal HealthOsteoarthritisAdolescentAdultAgedAged, 80 and overDisability-Adjusted Life YearsFemaleHumansIncidenceMaleMiddle AgedPrevalenceRisk FactorsYoung AdultGBDGlobalNationalOsteoarthritisRegionalSDI

Identifiers

PMID39702247
PMCPMC11660881

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.